In this session in partnership with Transcell Biologics we plan to showcase how AI-driven human microphysiological systems are transforming drug and vaccine testing.

The challenge is real: animal models have long been the bridge between discovery and the clinic — but the translational gap is costing lives and slowing breakthroughs. It's time for a smarter path forward.

Enter DART — a continuously learning human biology platform that integrates:

• Human Cells
• Human Microphysiological Systems (hMPS)
•  AI-powered Insights

...to simulate human physiology with unprecedented accuracy across the full drug development pipeline — from Discovery & Preclinical all the way to Personalising Therapies.

Applications span multiple areas including relative potency testing, NHP replacement studies, vaccine safety & efficacy, immunogenicity, tumor microenvironment modelling, biosimilar characterization, CAR-T dose personalization, and more.

Speaker: Dr. Subhadra Dravida, Founder & CEO, Transcell Biologics